Insights/Case studies/Newsroom/CareersCareersCareersPartnersConsultantsTechnology innovationCorporateEarly careersSearch Jobs/About us/Contact us Global locations

  • Phone
  • Contact us
  • Locations
  • Search
  • Menu


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Email this article
View or print a PDF of this page

Price hangs on patient outcomes

Andrew Jack
Financial Times
4 May 2010

PA health systems expert Steve Black has been quoted in the Financial Times.  Steve gives his views on the implications of a new model of payment by results which is emerging in healthcare. 

Commenting on the process of linking pharmaceutical prices more closely to patient outcomes, Steve says: “It is not uncommon for some classes of drugs to be effective in only one in three patients who take them.”

Steve cites anti-cancer treatments and psychoactive medicines as examples and concludes: “We might have to spend tens of thousands before knowing whether a drug will have any effect."

You can read Steve's views on data management here

To visit PA's heathcare pages, click here


Sign-up to receive company updates and press releases by email or newsfeed:



Corporate headquarters
10 Bressenden Place
London SW1E 5DN London SW1E 5DN
United Kingdom
Tel: +44 20 7333 5865 Tel: +44 20 7333 5865
contact us now

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.